Hunt Nimrata 4

What Happened
Hunt Nimrata, Executive Vice President of IDEXX Laboratories (IDXX), reported a sale of 2,693 shares on February 26, 2026. The filing shows a weighted-average sale price of $661.54 per share for total proceeds of $1,781,531. This was a disposition (sale), which is often routine and does not by itself indicate insider sentiment about the company.

Key Details

• Transaction date: 2026-02-26; Transaction type/code: Sale (S) — open market or private sale as reported.
• Shares sold: 2,693; Weighted-average price: $661.54; Total proceeds: $1,781,531.
• Price range (footnote): sales ranged from $661.35 to $661.8275 per share (footnote F1 notes the issuer can request per-price breakdown).
• Shares owned after transaction: Not disclosed in this Form 4.
• Filing date: 2026-02-27 (filed the next day — appears timely).
• No 10b5-1 plan, tax-withholding, or other special conditions are disclosed in this filing.

Context
Sales by executives can be for many routine reasons (diversification, tax planning, liquidity) and a single Form 4 sale should not be taken alone as a signal of company performance. Purchases typically carry more immediate informational weight for investors; this filing reports only a sale.